Clinical trial to evaluate ascorbic acid (vitamin C) and tocopherol (vitamin E) in combination versus placebo for the treatment of cognitive and behavioral disorders in children with fragile x syndrome

Registry ID

EUCTR2015-005460-42

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Start date

2016-07-07

Last update

2026-08-16

Conditions

• Fragile x syndrome

Summary

To Evaluate the safety, tolerability and efficacy of the combination of two antioxidants ascorbic acid and tocopherol, for the treatment of cognitive and behavioral disorders in children diagnosed of fragile X syndrome.

Locations

• , , Spain

View on source registry